Barcelona Clinical Trials Platform

Treballem per l’excel·lència en investigació i recerca

An iniciative by

  • Generalitat de Catalunya. Departament de Salut
  • Biocat

Bellvitge Biomedical Research Institute

Bellvitge University Hospital / Catalan Institute of Oncology Hospitalet / Viladecans Hospital

Hospital de Bellvitge
Institut Català d'Oncologia

Av. Gran Via de l'Hospitalet, 199. 08908 
l'Hospitalet de Llobregat, Barcelona 93 260 74 11

Contact person: 

Francisco Miguel Torres Grande 932607775 ext. 3333 

Team dedicated to clinical research: 

Most of the HUB staff devotes part of their time to research

415 Lead researchers

Core facilities: 
  • Facility for Phase I trials, part of the Farmaindustria BEST platform for excellence in clinical trials
  • Clinical Trials Unit
  • General support platform for researchers 

Bellvitge Biomedical Research Institute (IDIBELL) is a research center focused on cellular medicine, where high-level basic research centers on addressing relevant clinical issues and fostering economic development.

The IDIBELL brings together the biomedical research of the   Bellvitge University Hospital (HUB), Catalan Institute of Oncology (ICO), University of Barcelona Bellvitge campus (UB) and Viladecans Hospital (HV). It was one of the first five research centers in Spain to receive accreditation as a healthcare research institute from the   Institute of Health Carlos III (ISCIII) in 2009. It has facilities located at Duran i Reynals Hospital, Bellvitge University Hospital and at the University of Barcelona campus in Bellvitge. All of these are part of what is known as the Biopol'H space.

The center promotes and facilitates translational research of excellence, integrating innovation and transfer into biomedicine, in order to improve public health standards. Its aim is to be a global benchmark in biomedical research. The institute makes sure that its results always look towards innovation and transfer, thus having a positive impact on healthcare. 

Areas of clinical expertise 

The IDIBELL has more than 40 areas of clinical expertise, including Allergology, Pathological Anatomy, Anesthesiology and Reanimation, Angiology and Vascular Surgery, Digestive System, Cardiology, Surgery, Dermatology, Endocrinology and Nutrition, Pharmacy, Gynecology, Outpatient Care, Infectious Diseases, Internal Medicine, Nuclear Medicine, Preventative Medicine, Microbiology and Parasitology, Nephrology, Neurology, Ophthalmology, Pulmonology, Psychiatry, Radiodiagnosis, Urology, Medical Oncology, Radiotherapy Oncology, Clinical Hematology, Palliative Care and Epidemiology and Cancer Prevention, among others.

Recognition and distinctions

The IDIBELL is a health research institute accredited by the Institute of Health Carlos III (ISCIII). It is also an accredited CERCA center (Research Centers of Catalonia), participates in 8 CIBER groups (Biomedical Research Networking Centers) and has received HR Excellence in Research (HRS4R) accreditation. Moreover, it has also received 2 ERC Starting and Advanced grants, 4 ICREA grants (Catalan Institution for Research and Advanced Studies) and 2 ISIS grants.

Teaching specialties

The IDIBELL has 50 teaching specialties, including Allergology, Clinical Analysis, Pathological Anatomy, Anesthesiology and Reanimation, Angiology and Vascular Surgery, Digestive System, Clinical Biochemistry, Cardiology, Cardiovascular Surgery, General Surgery, Aesthetic and Reparative Plastic Surgery, Endocrinology and Nutrition, Clinical Pharmacology, Geriatrics, Hematology and Hemotherapy, Immunology, Occupational Medicine, Family and Community Medicine, Internal Medicine, Legal and Forensic Medicine, Nuclear Medicine, Preventative Medicine and Public Health, Microbiology and Parasitology, Nephrology, Pulmonology, Neurosurgery, Neurology, Obstetrics and Gynecology, Medial Oncology, Pediatrics, Clinical Psychology, Psychiatrics, Radiodiagnosis, Rheumatology and Urology, among others.